Nihon Kohden (OTCMKTS:NHNKY) Shares Gap Down – Here’s Why

Nihon Kohden Corporation (OTCMKTS:NHNKY) shares gapped down before the market opened on Friday . The stock had previously closed at $8.72, but opened at $8.2910. Nihon Kohden shares last traded at $8.38, with a volume of 7,415 shares changing hands.

Analyst Upgrades and Downgrades

Separately, Zacks Research upgraded shares of Nihon Kohden to a “hold” rating in a research note on Monday, April 27th. One analyst has rated the stock with a Strong Buy rating and one has given a Hold rating to the company. According to MarketBeat, Nihon Kohden currently has an average rating of “Buy”.

Nihon Kohden Price Performance

The stock has a market cap of $1.43 billion, a price-to-earnings ratio of 14.20 and a beta of 0.39. The business’s fifty day simple moving average is $9.28 and its 200 day simple moving average is $10.19.

Nihon Kohden (OTCMKTS:NHNKY) last released its quarterly earnings data on Thursday, May 14th. The company reported $0.34 EPS for the quarter, topping analysts’ consensus estimates of $0.24 by $0.10. Nihon Kohden had a net margin of 6.08% and a return on equity of 9.48%. The firm had revenue of $453.10 million during the quarter, compared to the consensus estimate of $414.40 million. As a group, equities analysts forecast that Nihon Kohden Corporation will post 0.61 EPS for the current fiscal year.

Nihon Kohden Company Profile

Nihon Kohden Corporation is a Tokyo-based manufacturer of medical electronic equipment, founded in 1951. The company has built a reputation for innovation in patient monitoring and diagnostic systems, developing one of Japan’s earliest electrocardiogram (ECG) machines and pioneering transistor-based oscilloscopes for clinical use. Over the decades, Nihon Kohden has expanded its product portfolio to address a wide range of healthcare needs, from emergency response to intensive care and neurology.

The company’s core offerings include patient monitors, ECG and electroencephalograph (EEG) devices, defibrillators, infusion pumps, and neuromonitoring systems.